Showing results (81-90 of 5,223) with videos related to
Sort By:
Pageof 523
European Archives of Psychiatry and Clinical Neuroscience|August 3, 2016
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depressionYukihiko Shirayama, Kenji HashimotoCurrent Pharmaceutical Design|March 2, 2011
α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophreniaMasatomo Ishikawa, Kenji HashimotoPlos One|December 15, 2010
A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AIKenji Hashimoto, Tamaki IshimaBrain Tumor Pathology|August 12, 2011
Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adultMasayuki Shintaku, Kenji HashimotoPlos One|June 2, 2012
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptorsTamaki Ishima, Kenji HashimotoAnnals of General Psychiatry|December 23, 2009
Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptorsTsutomu Furuse, Kenji HashimotoHuman Psychopharmacology|April 8, 2010
Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsideredIan Hindmarch, Kenji HashimotoThe Primary Care Companion for CNS Disorders|April 16, 2013
Beneficial effects of the sigma-1 agonist fluvoxamine for tardive dyskinesia in patients with postpsychotic depressive disorder of schizophrenia: report of 5 casesYakup Albayrak, Kenji HashimotoAnnals of General Psychiatry|February 12, 2010
Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's diseaseTsutomu Furuse, Kenji HashimotoAnnals of General Psychiatry|June 25, 2010
Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three casesTsutomu Furuse, Kenji HashimotoPageof 523